Erschienen in:
01.11.2005 | Adis Drug Profile
Rotigotine
A Viewpoint by Peter LeWitt
verfasst von:
Peter LeWitt
Erschienen in:
CNS Drugs
|
Ausgabe 11/2005
Einloggen, um Zugang zu erhalten
Excerpt
While the amino acid precursor of dopamine provides the most effective reversal of Parkinson’s disease (PD) symptomatology, other pharmacological options have joined levodopa in the dopaminergic armamentarium for this disorder. Drugs termed ‘dopaminergic agonists’ have been a major focus of drug development ever since the first of these, bromocriptine, was introduced in 1974. …